The Effect of Bevacizumab on the Trabeculectomy

• Status: Unknown status
• Trial end date: 2012-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators plan to evaluate the additive effect of intracameral and subconjunctival injections of bevacizumab in trabeculectomies with other antimetabolites.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Samsung Medical Center
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• glaucoma patients who have trabeculectomy

Exclusion Criteria:

• patients with the other ocular disease